Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation
Background: Immune and inflammatory processes have known contributions to the pathogenesis of myelodysplastic syndromes (MDS). The use of inflammatory markers, minimally used in current practice, is examined.
Saved in:
| Main Authors: | Howard Oster, Ekaterina Sklyar, Noa Golsdshmidt, Moshe Mittelman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2023-06-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://mjhid.org/index.php/mjhid/article/view/5376 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM
by: May Basood, et al.
Published: (2018-07-01) -
Etiological classification of high sedimentation rate and relation with other inflammatory markers
by: Sultan Gozde Temiz, et al.
Published: (2024-04-01) -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01) -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01) -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
by: Rosangela Invernizzi, et al.
Published: (2015-04-01)